Immunohistochemical localization of hepatic nitric oxide synthase in normal and transgenic sickle cell mice: the effect of hypoxia.
暂无分享,去创建一个
R. Nagel | R. Ahima | N. Bank | M. Fabry | S. Osei | Ronald L. Nagel | Norman Bank
[1] R. Nagel,et al. Renal nitric oxide synthases in transgenic sickle cell mice. , 1996, Kidney international.
[2] M. Lerch,et al. The role of nitric oxide in hemodynamic and metabolic alterations induced by prostaglandin F2α in the perfused rat liver , 1995 .
[3] E. Connolly,et al. Hypoxia and modification of the endothelium: implications for regulation of vascular homeostatic properties. , 1995, Seminars in cell biology.
[4] J. Hofrichter,et al. A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity. , 1995, Blood.
[5] C. Foster,et al. Chronic intrahepatic cholestasis in sickle cell disease requiring exchange transfusion. , 1995, Gut.
[6] H. Ischiropoulos,et al. Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. , 1995, Gastroenterology.
[7] T. Billiar. The delicate balance of nitric oxide and superoxide in liver pathology. , 1995, Gastroenterology.
[8] J. Polak,et al. Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[9] C. Nathan,et al. The high‐output nitric oxide pathway: role and regulation , 1994, Journal of leukocyte biology.
[10] R. Schrier,et al. Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[11] H. Miki,et al. Prostaglandin E1 abrogates early reductive stress and zone-specific paradoxical oxidative injury in hypoperfused rat liver. , 1994, The Journal of clinical investigation.
[12] T. Hoang,et al. Sickle cell disease of transgenic SAD mice. , 1994, Blood.
[13] Joseph Loscalzo,et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds , 1993, Nature.
[14] E. Lapetina,et al. Hepatocytes and macrophages express an identical cytokine inducible nitric oxide synthase gene. , 1993, Biochemical and biophysical research communications.
[15] C. Lowenstein,et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[16] R. Nagel,et al. High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Nagel,et al. High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[18] D. Pinsky,et al. Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. , 1992, The Journal of clinical investigation.
[19] T. Billiar,et al. Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia , 1992, Critical care medicine.
[20] J. Crawford,et al. Hypoxic liver injury and the ameliorating effects of fructose: the "glucose paradox" revisited. , 1992, The American journal of physiology.
[21] A. Nussler,et al. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin , 1992, The Journal of experimental medicine.
[22] S. Moncada,et al. Protective and pathological roles of nitric oxide in endotoxin shock. , 1992, Cardiovascular research.
[23] R. Johns,et al. Characterization of endothelium-derived relaxing factor/nitric oxide synthase from bovine cerebellum and mechanism of modulation by high and low oxygen tensions. , 1991, The Journal of pharmacology and experimental therapeutics.
[24] E. Rubin,et al. Hypoxia-induced in vivo sickling of transgenic mouse red cells. , 1991, The Journal of clinical investigation.
[25] R. L. Simmons,et al. Modulation of Nitrogen Oxide Synthesis In Vivo: NG‐Monomethyl‐L‐Arginine Inhibits Endotoxin‐Induced Nitrate/Nitrate Biosynthesis While Promoting Hepatic Damage , 1990, Journal of leukocyte biology.
[26] T. Schubert. Hepatobiliary system in sickle cell disease. , 1986, Gastroenterology.
[27] M. Omata,et al. Liver Involvement in Sickle Cell Disease , 1985, Medicine.
[28] J. Lemasters,et al. Cell surface changes and enzyme release during hypoxia and reoxygenation in the isolated, perfused rat liver , 1983, The Journal of cell biology.
[29] S. Ballas,et al. Clinical, hematological, and biochemical features of Hb SC disease , 1982, American journal of hematology.
[30] J. Lemasters,et al. Centrilobular injury following hypoxia in isolated, perfused rat liver. , 1981, Science.
[31] G. Hutchins,et al. The liver in sickle cell disease. A clinicopathologic study of 70 patients. , 1980, The American journal of medicine.
[32] W. Lautt. Method for measuring hepatic uptake of oxygen or other blood-borne substances in situ. , 1976, Journal of applied physiology.
[33] I. W. Mclean,et al. PERIODATE-LYSINE-PARAFORMALDEHYDE FIXATIVE A NEW FIXATIVE FOR IMMUNOELECTRON MICROSCOPY , 1974, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.